Outlook Therapeutics, Inc. OTLK 深 沪
等待开盘 06-26 09:30:00 美东时间
1.605
-0.060
-3.60%
华盛通- 最 高1.88
- 今 开1.66
- 成交量 867.82万股
- 最 低 1.47
- 昨 收 1.665
- 总市值 36.27万
- 52周最高 3.39
- 市盈率 静 --
- 换手率 3839.90%
- 52周最低 0.1611
- 委 比 90.17%
- 总股本 0.00亿
- 历史最高 12.8499
- 量 比 0.55
- 振 幅 24.62%
- 历史最低 0.12
- 每 手 1
- 风险率 0.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Outlook Therapeutics Eye Drug Review Returns To FDA For Fourth Time
Outlook Therapeutics shares rose after the FDA accepted its resubmitted LYTENAVA BLA and set a July 2026 target action date.
06-17 20:39
Outlook Shares Jump Following FDA Appeal Decision For LYTENAVA
Outlook Therapeutics Inc. shares are trading higher Tuesday after the FDA granted its appeal in the ONS-5010 dispute resolution process.
05-26 21:16
Outlook Therapeutics Terminates Offering Agreement With BTIG Effective May 12
Effective May 12, 2026, Outlook Therapeutics canceled its at-the-market sales agreement, dated as of May 16, 2023 (as amended, the "Prior Sales Agreement") with BTIG, LLC with respect to an at-the-market offering program
05-14 04:52
Outlook Therapeutics Enter $100M Offering Agreement With H.C. Wainwright
On May 13, 2026, Outlook Therapeutics, Inc. (the "Company") entered into an At The Market Offering Agreement (the "Sales Agreement") with H.C. Wainwright & Co., LLC ("H.C. Wainwright"), pursuant to which the Company
05-14 04:49
Outlook Therapeutics Reveals Proposed Public Offering; No Size Disclosed
Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced a best-efforts
03-24 05:35
Outlook Therapeutics Earnings Report: Q1 Overview
The Q1 earnings report for Outlook Therapeutics (NASDAQ:OTLK) was released on T...
02-17 21:12
Outlook Therapeutics Stock Sinks After FDA Rejects Eye Drug Again
Outlook Therapeutics' stock fell to a new low due to FDA rejection of its Lytenava filing for wet AMD. Efficacy evidence remains key issue.
01-02 21:18
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Shares of Baidu Inc (NASDAQ:BIDU) rose sharply in pre-market trading after the ...
01-02 17:30
Apple, Taiwan Semiconductor Manufacturing And 3 Stocks To Watch Heading Into Friday (CORRECTED)
U.S. stock futures up, Apple reduces Vision Pro production, TSMC gets U.S. export license, VS Media announces share combination.
01-02 15:19
Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event
Outlook Therapeutics will participate in a Virtual Investor Lunch Break Event on June 25th at 12:00 PM ET. Lawrence Kenyon, Jeff Evanson, and Jedd Comiskey will discuss the company’s commercial strategy, upcoming milestones, and current activities. A live webcast and replay will be available on the company’s website. Outlook Therapeutics is focused on advancing ONS-5010/LYTENAVA™ (bevacizumab-vikg) for retina diseases.
2025-06-18 13:05
